Navigation Links
San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer
Date:3/16/2010

SAN DIEGO, March 16 /PRNewswire/ -- SpineMark CRO Management, a wholly-owned subsidiary of San Diego based SpineMark Corporation, recently signed an agreement with Ranier Technology, a Cambridge, England based spinal medical device manufacturer, to provide contract research support services for the Ranier CAdisc™-L clinical trial, a 3rd generation lumbar total disc replacement device for treatment of degenerative disc disease in the lumbar spine.  SpineMark CRO Management provides site recruitment including utilization of principal investigators from its network of sites, reimbursement strategy development, payor education, trial management, site training, patient recruitment, data management, monitoring, regulatory advice and general oversight to allow Ranier to effectively complete their FDA requirements for approval of new spinal devices.  

"The SpineMark CRO model provides intermediary third party oversight to ensure that the highest quality of monitoring, management and resources can be brought to bear for Ranier, as well as the patients and physicians participating in this trial," explains Marcy Rogers, President and CEO of SpineMark.

The CAdisc™-L design, materials and biomechanics represent a significant clinical advance in the treatment of degenerative disc disease in the lumbar spine.  

"I am delighted to be working with SpineMark. Their specialized dedication to clinical research in spine, their relationships, and their ability to manage various aspects of the US clinical trial process makes them a perfect fit for our study," explains Dr. Geoffrey Andrews, CEO of Ranier Technology.

SpineMark offers an international medical advisory board and access to SpineMark's network of leading physicians and surgeons across the country. The corporation is an expert in FDA regulations and protocol, offering site operations support and training, contract negotiation and financial management, regulatory and compliance oversight and marketing and media relations.  

For more information on SpineMark CRO Management visit www.spinemarkCRO.com

For more information on Ranier Technology Limited visit www.ranier.co.uk

SOURCE SpineMark Corporation

Back to top

RELATED LINKS
http://www.spinemark.com
http://www.spinemarkCRO.com
http://www.ranier.co.uk/

'/>"/>

SOURCE SpineMark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
2. PG500 Series Presented at the AACR Annual Meeting in San Diego
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
7. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
8. Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
9. California American Water Celebrates No Drugs Down the Drain Week in San Diego
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
Breaking Medicine Technology:
(Date:4/24/2017)... RICHEY, Fla. (PRWEB) , ... April 24, 2017 ... ... and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives of ... slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
Breaking Medicine News(10 mins):